GB9928430D0 - Screening - Google Patents
ScreeningInfo
- Publication number
- GB9928430D0 GB9928430D0 GBGB9928430.9A GB9928430A GB9928430D0 GB 9928430 D0 GB9928430 D0 GB 9928430D0 GB 9928430 A GB9928430 A GB 9928430A GB 9928430 D0 GB9928430 D0 GB 9928430D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- screening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9928430.9A GB9928430D0 (en) | 1999-12-01 | 1999-12-01 | Screening |
EP00988766A EP1244786A1 (en) | 1999-12-01 | 2000-11-30 | Screening method for compounds capable of modularing egr-1-regulated expression |
AU25092/01A AU2509201A (en) | 1999-12-01 | 2000-11-30 | Screening method for compounds capable of modularing egr-1-regulated expression |
US10/148,055 US20030124554A1 (en) | 1999-12-01 | 2000-11-30 | Screening method for compounds capable of modularing egr-1-regulated expression |
PCT/EP2000/011997 WO2001040460A1 (en) | 1999-12-01 | 2000-11-30 | Screening method for compounds capable of modularing egr-1-regulated expression |
JP2001542527A JP2003515339A (en) | 1999-12-01 | 2000-11-30 | Screening method for compounds capable of regulating EGR-1 regulatory expression |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9928430.9A GB9928430D0 (en) | 1999-12-01 | 1999-12-01 | Screening |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9928430D0 true GB9928430D0 (en) | 2000-01-26 |
Family
ID=10865529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9928430.9A Ceased GB9928430D0 (en) | 1999-12-01 | 1999-12-01 | Screening |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1244786A1 (en) |
JP (1) | JP2003515339A (en) |
AU (1) | AU2509201A (en) |
GB (1) | GB9928430D0 (en) |
WO (1) | WO2001040460A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007106488A2 (en) * | 2006-03-13 | 2007-09-20 | Wyeth | Modulators of gluconeogenesis |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5763209A (en) * | 1988-09-26 | 1998-06-09 | Arch Development Corporation | Methods and materials relating to the functional domains of DNA binding proteins |
AUPN855496A0 (en) * | 1996-03-07 | 1996-04-04 | Unisearch Limited | Prevention of proliferation of vascular cells |
ES2205830T3 (en) * | 1998-06-02 | 2004-05-01 | Glaxo Group Limited | EGR-1 FOR THE PREPARATION OF A MEDICINAL PRODUCT TO TREAT WOUNDS. |
IL140533A0 (en) * | 1998-07-11 | 2002-02-10 | Glaxo Group Ltd | Pharmaceutical uses of nab1 and nab2 |
-
1999
- 1999-12-01 GB GBGB9928430.9A patent/GB9928430D0/en not_active Ceased
-
2000
- 2000-11-30 JP JP2001542527A patent/JP2003515339A/en active Pending
- 2000-11-30 AU AU25092/01A patent/AU2509201A/en not_active Abandoned
- 2000-11-30 EP EP00988766A patent/EP1244786A1/en not_active Withdrawn
- 2000-11-30 WO PCT/EP2000/011997 patent/WO2001040460A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2509201A (en) | 2001-06-12 |
JP2003515339A (en) | 2003-05-07 |
WO2001040460A8 (en) | 2001-11-08 |
WO2001040460A1 (en) | 2001-06-07 |
EP1244786A1 (en) | 2002-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE50002490D1 (en) | Polyester-polyetherblockcopolymere | |
DE50008011D1 (en) | Thixotropierungsmittel | |
DE50002614D1 (en) | Sigma-delta-modulator | |
GB9904991D0 (en) | Genetic screening | |
GB2356809B (en) | Screens | |
DE50000137D1 (en) | Spirofluorenopyrane | |
GB9922352D0 (en) | Screening method | |
DE10081629D2 (en) | Seilzugbefestigung | |
EP1175268A4 (en) | Screening equipment | |
GB9923075D0 (en) | Screening method | |
EP1237001A4 (en) | Screening method | |
HK1048307A1 (en) | Substituted heterocyclyl-2h-chromenes | |
GB2349217B (en) | Compound screening methods | |
DE50008218D1 (en) | Common-rail-injektor | |
AU141428S (en) | Turnpiece | |
GB9911456D0 (en) | Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives | |
GB9902696D0 (en) | Screening methods | |
GB2350070B (en) | Screening apparatus | |
PL352101A1 (en) | Substituted phenylcyclohexanocarboxyamides | |
GB9930255D0 (en) | Screening method | |
GB9924929D0 (en) | Screening apparatus | |
GB9928430D0 (en) | Screening | |
DE50005334D1 (en) | Tricyclische benzoylcyclohexandion-derivate | |
AU140373S (en) | Bumbag | |
GB9901979D0 (en) | Screening device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |